Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.
With the Covid-19 pandemic increasingly forcing healthcare testing, diagnosis and treatment online, the promise of augmented and virtual reality is drawing deepening interest in Asia’s medtech market.
Diagnostic companies are hustling to increase availability of testing.
From artificial intelligence to autonomous sterilization robots to drones, emerging technologies are playing a strong role in combating COVID-19.
The self-driving UV disinfection robots are being sent to more than 2000 hospitals.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
The adoption of accurate non-invasive measures of liver health at the point of care is critical.